Chromedx Corp (MNLIF) 0.1910 $MNLIF ChroMedx Reports

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chromedx Corp (MNLIF) 0.1910 $MNLIF

ChroMedx Reports Testing of Key HemoPalm Analyzer Component
ACCESSWIRE - Tue Sep 08, 3:31PM CDT
TORONTO, ON / ACCESSWIRE / September 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that testing has commenced on the key spectroscopic component of the Analyzer of HemoPalm(TM) blood analysis device.

ChroMedX Announces Completion of HemoPalm(TM) Prototype Cartridge
ACCESSWIRE - Fri Sep 04, 3:40PM CDT
TORONTO, ON / ACCESSWIRE / September 4, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report the completion of the HemoPalm(TM) System Prototype Cartridge.

ChroMedX Engages Polygenesis Corporation for Completion of HemoPalm(TM) Alpha
ACCESSWIRE - Wed Sep 02, 3:39PM CDT
TORONTO, ON / ACCESSWIRE / September 2, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of technology development and prototyping firm Polygenesis Corporation to continue the development of the HemoPalm(TM) biosensor array, a fundamental component of the HemoPalm(TM) system.

ChroMedX Submits PCT Patent Application for HemoPalm(TM) Blood Analysis System
ACCESSWIRE - Fri Aug 28, 3:38PM CDT
TORONTO, ON / ACCESSWIRE / August 28, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a PCT (Patent Cooperation Treaty) Patent Application pertaining to the HemoPalm(TM) Cartridge and Analyzer system called "Joint Spectroscopic and Biosensor System for Point-of-Care Testing" (PCT/CA2015/050455).

ChroMedX Corp. Announces OTCQB Listing
ACCESSWIRE - Tue Aug 04, 1:11PM CDT
TORONTO, ON / ACCESSWIRE / August 4, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (Frankfurt: EIY2.F) (the "Company" , a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that its common shares recently commenced trading on the OTCQB(R), under the symbol "MNLIF." Real-time quotes and market information on the Company are available at http://www.otcmarkets.com/stock/MNLIF/quote

ChroMedX Corp. Closes Private Placement of Units
Newsfile Corp - Fri Jul 10, 3:11PM CDT
full story)

ChroMedX Announces Private Placement of Units
Newsfile Corp - Tue Jul 07, 3:15PM CDT
full story)

ChroMedX Welcomes Dr. Nick Smit to Biosensor Development Team
ACCESSWIRE - Wed Mar 25, 3:56PM CDT
TORONTO, ON / ACCESSWIRE / March 25, 2015 / ChroMedX Corp. (CSE: CHX) (PINKSHEETS: MNLIF) (Frankfurt: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the engagement of Dr. Nick Smit as part of the HemoPalm biosensor development team.

ChroMedX Appoints Dr. Robert Smyth to Technical Advisory Board
ACCESSWIRE - Tue Mar 24, 3:23PM CDT
TORONTO, ON / ACCESSWIRE / March 24, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company" , a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the appointment of anesthesiologist Dr. Robert Smyth to the Company's Technical Advisory Board.

ChroMedX Collaborates with Microfluidic and Microfabrication Experts for HemoPalm Cartridge Development
ACCESSWIRE - Mon Mar 23, 3:39PM CDT
TORONTO, ON / ACCESSWIRE / March 23, 2015 / ChroMedX Corp. (CSE: CHX) (PINKSHEETS: MNLIF) (FSE: EIY2) (the "Company" , a developer of in vitro diagnostics and point-of-care technologies is pleased to announce it has entered into a collaboration with Dr. Ravi Selvaganapathy of McMaster University to assist in the design and development of prototype cartridges for the Company's patented HemoPalm blood analyzer system.

ChroMedX Submits US Provisional Patent Application for Recently Developed Aspects of HemoPalm Blood Analysis System
ACCESSWIRE - Tue Mar 10, 2:35PM CDT
TORONTO, ON / ACCESSWIRE / March 10, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company" , a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a second US Provisional Patent Application pertaining to the HemoPalm Cartridge and Analyzer system.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 688

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 531

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 220

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 382

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Nutex Health Inc: Understanding Recent Legal Developments

Updated Category News Views 119

Overview of Nutex Health Inc. Nutex Health Inc. (NASDAQ: NUTX) is a key player in the healthcare sector, known for its innovative services and strategies aimed at enhancing patient care. As investors, it is crucial to stay informed about potential impacts to the company’s stock due to various legal challenges. Recent Legal Actions Recently, the law firm Kirby McInerney...

Continue Reading
Cyber Threats: 65% of Firms Fear Survival Risks

Updated Category News Views 18

A Wake-Up Call for Businesses If you thought the cyber threats were just a sideshow, think again. Sixty-five percent of businesses are tossing around the notion that a serious cyber attack could knock them out for good. Databarracks just unveiled its 2026 Data Health Check, airing out the gloomy stats we frankly can't ignore anymore. Cyber Attacks: More Than Just a...

Continue Reading
Understanding the Recent Supplementary Prospectus Release

Updated Category News Views 122

Overview of the Supplementary Prospectus Hargreave Hale AIM VCT plc has recently released a supplementary prospectus approved by the Financial Conduct Authority. This document is essential for investors seeking to understand recent developments regarding the company's financial situation. Purpose of the Supplementary Prospectus The supplementary prospectus is a regulatory...

Continue Reading
Carbliss Celebrates Launch in Arizona After Record Growth

Updated Category News Views 170

Carbliss Launches in Arizona: A Significant Expansion Carbliss has officially launched in Arizona, enhancing its reach and marking a pivotal point in the brand's journey. This premium ready-to-drink cocktail brand, known for its zero sugar, zero carb, and 100 calorie beverages, has made a notable impact in the beverage industry through a focus on quality and consumer...

Continue Reading
MicroStrategy's Bold Investment in Bitcoin Sparks Debate

Updated Category News Views 85

MicroStrategy's Bold Investment Strategies As the world watches Bitcoin prices soar to new heights, MicroStrategy's aggressive accumulation of Bitcoin has become a hot topic in the crypto community. Many traders and analysts are scrutinizing the company's strategy as it continues to amass significant Bitcoin holdings. Understanding Recent Developments Industry expert Alex...

Continue Reading